Drug Trial Radar · NCT02481882
Baseline Cortical Haemodynamics in MS
Last checked: Nov 19, 2026Latest source record: Oct 12, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
80
Planned (sponsor's estimate)
Start
Jan 2017
Primary completion
Oct 2019
Study completion Oct 2019
Sponsor
- Lead sponsor
- University of NottinghamAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 25, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- Who can join
- All sexes, from 21 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will provide information on cortical haemodynamics in MS patients to address the discrepancies reported in previous literature, allowing further insight into the role of haemodynamics in the disease. It will also instruct us as to the most effective scanning protocols for future research. Developing a suitable protocol for studying perfusion longitudinally may also enable identification of new therapeutic interventions to normalise any perfusion abnormalities in MS patients.
Conditions
- Multiple Sclerosis
Interventions
Magnetic Resonance ImagingDevice
All scanning will be performed using a 7 Tesla Philips Achieva scanner with multi-transit capability (Philips Medical Systems, Best, The Netherlands). The volunteers will be scanned with a 32-channel receive coil.
Prohance (Gadoteridol)Drug
A gadolinium based liquid administered intravenously in order to quantify blood flow in the brain using an MR scanner.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cerebral Blood FlowTime frame: 1 hour
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Queen's Medical Centre
Nottingham, Nottinghamshire, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.